We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Explains Reporting Requirements for CE-Marked Coronary Stents
UK Explains Reporting Requirements for CE-Marked Coronary Stents
January 13, 2009
Some adverse events involving coronary stents are subject to periodic summary reporting at six-month intervals, according to a new guidance by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor